The global Collagenase market is projected to expand significantly, growing from an estimated $83 million in 2024 to approximately $110 million by 2032. This growth reflects a compound annual growth rate (CAGR) of 3.2%. Factors contributing to market expansion include increased demand for collagenase in medical treatments, wound care, and scientific research. Historical data from 2018 to 2023 indicates steady market progression, primarily driven by biotechnology advancements and heightened investments in regenerative medicine.